A pair of adhesion receptors work together to fi ne-tune suppression of RhoA and promote membrane protrusion, say Bass et al.
During cell migration, the actin cytoskeleton regulator, RhoA, must be alternately inhibited (to allow the leading membrane edge to protrude) and reactivated (to pull up the trailing end of the cell from behind). Inhibition occurs when a receptor called α5β1 integrin, which binds to the extracellular matrix protein, fi bronectin, triggers phosphorylation of a RhoA inhibitor called p190RhoGAP-A (p190-A). Another fi bronectin receptor, syndecan-4, colocalizes with integrin during RhoA inhibition, but whether this second receptor contributes to inhibition was unknown.
By treating cells with fragments of fi bronectin that bound to syndecan-4 but not integrin, the authors showed that syndecan-4 triggered transient relocation of p190-A to the membrane, which correlated with reduced RhoA activity. Syndecan-4 is known to activate PKCα, and exogenous activation of PKCα is known to trigger phosphorylation and mem brane recruitment of p190-A. Bass et al. connected the dots by showing that loss of syndecan-4 function reduced relocation of p190-A to the membrane. Although integrin phosphorylates p190-A at a tyrosine, syndecan-4 phosphorylated a serine. Neither integrin nor syndecan alone induced the normal Rho-related pattern of cell spreading, suggesting that a combination of these two receptors is needed for full inhibition of RhoA.
p190-A is the convergence point for signaling from these two independent adhesion receptors, the authors conclude. Although the two receptors colocalize during leading edge protrusion, syndecan-4, a lengthy protein, can stretch itself up to 500 nm from the cell. Syndecan-4 might therefore act as an exploratory receptor, whereas the shorter integrin may anchor the leading edge. In this model, p190-A serves to integrate information from both near and far. R ecombination at centromeres is higher than anywhere else on the chromosome, even though methyltransferases do their best to prevent it, say Jaco et al. Centromeric recombination has been hard to study because the DNA at centromeres is so repetitive-it's hard to see when a segment has switched chromatids. Jaco et al. have now addressed this challenge by using CO-FISH (chromosome orientation fl uorescence in situ hybridization). After replication, the two new strands are digested away, leaving the two old strands. Because the strands are complementary in sequence, they can be tagged with strand-specifi c fl uorescent probes. Using just one probe, only one chromatid would show a signal if no recombination had occurred.
Instead, the authors found that both chromatids fl uoresced. And not just at one point-on average, the authors counted, centromeres had undergone 15 recombination events. This is about six times the rate of recombination as that seen for an equal length of telomeric DNA, and 175 times the rate for genomic DNA as a whole.
Telomeric recombination is inhibited by protein complexes called shelterins and by DNA methylation. The centromere has no shelterin, but it is methylated. Knockdown of DNA methyltransferases increased recombination at the centromere by about 50%, and decreased centromere length, possibly because of misalignment between repeated segments during recombination, a common problem with repetitive DNA. How methylation limits recombination, and why centromeres didn't lengthen as well as shorten, are unknown.
Their repetitive structure makes centromeres recombinogenic by nature, and the authors suggest that epigenetic regulation may ensure the continued stability of essential binding regions for proteins that link to the centromere. 
Centromeres cross over, a lot

